Outcome of hepatocellular carcinoma in human immunodeficiency virus-infected patients

Digestive and Liver Disease

Volumn 45, Issue 6, 2013, Pages 516-522

  Gramenzi, Annagiulia ^a   Tedeschi, Sara ^a   Cantarini, Maria Chiara ^a   Erroi, Virginia ^a   Tumietto, Fabio ^a   Attard, Luciano ^a   Calza, Leonardo ^a   Foschi, Francesco Giuseppe ^b   Caraceni, Paolo ^a   Pavoni, Michele ^a   Cucchetti, Alessandro ^a   Bernardi, Mauro ^a   Viale, Pierluigi ^a   Verucchi, Gabriella ^a   Trevisani, Franco ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Faenza Hospital   (Italy)

Author keywords

Cirrhosis; HIV infection; Liver cancer; Prognosis

Indexed keywords

ALPHA FETOPROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIVIRAL THERAPY; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; CHARLSON COMORBIDITY INDEX; CHEMOEMBOLIZATION; CHRONIC LIVER DISEASE; COMORBIDITY; CONTROLLED STUDY; DRUG USE; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CELL CARCINOMA; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; THROMBOCYTE COUNT;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPENSITY SCORE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84878127387     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2012.12.010     Document Type: Article

References (36)

1. Rosenthal E., Salmon-Céron D., Lewden C., et al. Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalité 2005 survey). HIV Medicine 2009, 10:282-289.
2. Sahasrabuddhe V.V., Shiels M.S., McGlynn K.A., et al. The risk of hepatocellular carcinoma among individuals with acquired immunodeficiency syndrome in the United States. Cancer 2012, 2:6. [Epub ahead of print]. 10.1002/cncr.27694.
3. Puoti M., Torti C., Bruno R., et al. Natural history of chronic hepatitis B in co-infected patients. Journal of Hepatology 2006, 44:S65-S70.
4. Massard J., Ratziu V., Thabut D., et al. Natural history and predictors of disease severity in chronic hepatitis C. Journal of Hepatology 2006, 44:S19-S24.
5. Kramer J.R., Giordano T.P., Souchek J., et al. The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C. American Journal of Gastroenterology 2005, 100:56-63.
6. Posthouwer D., Makris M., Yee T.T., et al. Progression to end-stage liver disease in patients with bleeding disorders and hepatitis C: an international, multicenter cohort study. Blood 2007, 109:3667-3671.
7. Puoti M., Bruno R., Soriano V., et al. Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. AIDS 2004, 18:2285-2293.
8. Brau N., Fox R.K., Xiao P., et al. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study. Journal of Hepatology 2007, 47:527-537.
9. Bourcier V., Winnock M., Ait Ahmed M., et al. Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir). Clinics and Research in Hepatology and Gastroenterology 2012, 36:214-221.
10. Berretta M., Garlassi E., Cacopardo B., et al. Hepatocellular carcinoma in HIV-infected patients: check early, treat hard. Oncologist 2011, 16:1258-1269.
11. Clifford G.M., Rickenbach M., Polesel M., et al. Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma. AIDS 2008, 22:2135-2141.
12. 4): a prospective cohort study. Lancet Oncology 2009, 10:1152-1159.
13. 3 Aquitaine Cohort, France, 1998-2008. Journal of Hepatology 2011, 55:1058-1062.
14. Macdonald D.C., Nelson M., Bower M., et al. Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era. World Journal of Gastroenterology 2008, 14:1657-1663.
15. McGinnis K.A., Fultz S.L., Skanderson M., et al. Hepatocellular carcinoma and non-Hodgkin's lymphoma: the roles of HIV, hepatitis C infection and alcohol abuse. Journal of Clinical Oncology 2006, 24:5005-5009.
16. Murillas J., Del Rio M., Riera M., et al. Increased incidence of hepatocellular carcinoma (HCC) in HIV-1 infected patients. European Journal of Internal Medicine 2005, 16:113-115.
17. Qurishi N., Kreuzberg C., Luchters G., et al. Effects of antiretroviral therapy on liver related mortality in patients with HIV and hepatitis C virus coinfection. Lancet 2003, 362:1708-1713.
18. Smukler A.J., Ratner L. Hepatitis viruses and hepatocellular carcinoma in HIV-infected patients. Current Opinion in Oncology 2002, 14:538-542.
19. Giordano P.T., Kramer J.R., Soucheck J., et al. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus. Archives of Internal Medicine 2004, 164:2349-2354.
20. Pineda J., Romero-Gomez M., Diaz-Garcia F., et al. HIV confection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. Hepatology 2005, 41:779-789.
21. Garcia-Garcia J.A., Romero-Gomez M., Giron-Gonzalez J.A., et al. Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis. AIDS Research and Human Retroviruses 2006, 22:1236-1241.
22. Pineda J.A., Garcia-Garcia J.A., Aguilar-Guisao M., et al. Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy. Hepatology 2007, 46:622-630.
23. Degos F., Tural C. Hepatocellular carcinoma in human immunodeficiency virus (HIV)-infected patients: is it really different, and if so, why. Journal of Hepatology 2007, 47:447-450.
24. Garcia-Samaniego J., Rodriguez M., Berenguer J., et al. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. American Journal of Gastroenterology 2001, 96:179-183.
25. Lim C., Goutte N., Gervais A., et al. Standardized care management ensures similar survival rates in HIV-positive and HIV-negative patients with hepatocellular carcinoma. Journal of Acquired Immune Deficiency Syndromes 2012, 22. [Epub ahead of print].
26. Charlson M., Szatrowski T.P., Peterson J., et al. Validation of a combined comorbidity index. Journal of Clinical Epidemiology 1994, 47:1245-1251.
27. Pugh N.H., Murray-Lyon I.M., Dawson J.L., et al. Transection of the oesophagus for bleeding oesophageal varices. British Journal of Surgery 1973, 60:646-649.
28. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 2000, 31:840-845. The Cancer of the Liver Italian Program (CLIP) Investigators.
29. Commissione Epatocarcinoma dell'Associazione Italiana per lo Studio del Fegato Epatocarcinoma: Linee Guida per la Diagnosi e la Terapia 1998, Tipografia Moderna, Bologna, p. 235-86.
30. Bruix J., EASL Panel of Experts on HCC Clinical management of hepatocellular carcinoma. Conclusion of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. Journal of Hepatology 2001, 35:421-430.
31. Bruix J., Sherman M. Management of hepatocellular carcinoma: AASLD Practice Guideline. Hepatology 2005, 42:1208-1236.
32. Centers for Disease Control and Prevention 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR - Morbidity and Mortality Weekly Report 1992, 41:1-19.
33. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. Department of Health and Human Services; January 10, 2011. pp. 1-166. Available from: [accessed 05.04.12]. http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
34. D'Agostino R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non randomized control group. Statistics in Medicine 1998, 17:2265-2281.
35. Mirici-Cappa F., Gramenzi A., Santi V., et al. Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience. Gut 2010, 59:387-396.
36. Trevisani F., Frigerio M., Santi V., et al. Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal. Digestive and Liver Disease 2010, 42:341-347.